"This fund primarily invests in common stocks. Typically, at least 80% of its assets are dedicated to companies actively involved in the discovery, advancement, production, and sale of biotechnology-related offerings (products, services, and processes), as well as companies positioned to significantly gain from scientific and technological breakthroughs in biotechnology. The fund's holdings include both U.